Short Interest in Sonova Holding (OTCMKTS:SONVY) Drops By 77.6%

Sonova Holding (OTCMKTS:SONVY) saw a large drop in short interest in January. As of January 30th, there was short interest totaling 8,247 shares, a drop of 77.6% from the January 15th total of 36,769 shares. Currently, 0.0% of the company’s stock are sold short. Based on an average trading volume of 47,269 shares, the short-interest ratio is presently 0.2 days. Based on an average trading volume of 47,269 shares, the short-interest ratio is presently 0.2 days. Currently, 0.0% of the company’s stock are sold short.

Analysts Set New Price Targets

SONVY has been the subject of a number of research reports. Royal Bank Of Canada upgraded Sonova to a “moderate buy” rating in a research note on Tuesday, November 18th. Zacks Research downgraded Sonova from a “hold” rating to a “strong sell” rating in a report on Tuesday, December 9th. Finally, BNP Paribas Exane assumed coverage on Sonova in a report on Monday, October 20th. They issued an “underperform” rating for the company. One investment analyst has rated the stock with a Strong Buy rating, one has given a Buy rating, three have issued a Hold rating and three have given a Sell rating to the stock. Based on data from MarketBeat.com, the stock presently has a consensus rating of “Hold”.

Sonova Stock Down 0.2%

Shares of Sonova stock opened at $53.40 on Wednesday. Sonova has a twelve month low of $47.55 and a twelve month high of $68.76. The company has a current ratio of 1.24, a quick ratio of 0.91 and a debt-to-equity ratio of 0.51. The business’s 50 day simple moving average is $52.89 and its 200-day simple moving average is $54.48.

About Sonova

Sonova AG (OTCMKTS:SONVY) is a Switzerland-based provider of hearing care solutions, headquartered in Stäfa. The company designs, develops, manufactures and distributes a range of audiological products and related services aimed at improving hearing and communication for people with hearing loss. Its portfolio spans behind-the-ear and in-the-ear hearing instruments, wireless accessories and software solutions that enable connectivity with consumer devices and audiological fittings.

Sonova markets its products under several well-known brands, including Phonak and Unitron for hearing aids, and it is also associated with Advanced Bionics for cochlear implant systems.